Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities-Reference-Cited by-同舟云学术

Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities

Published:2020-10-12 Issue:11 Volume:130 Page:6021-6033
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Magnani Chiara F.^ORCID,Gaipa Giuseppe,Lussana Federico^ORCID,Belotti Daniela,Gritti Giuseppe^ORCID,Napolitano Sara,Matera Giada,Cabiati Benedetta,Buracchi Chiara,Borleri Gianmaria,Fazio Grazia^ORCID,Zaninelli Silvia,Tettamanti Sarah,Cesana Stefania,Colombo Valentina,Quaroni Michele,Cazzaniga Giovanni^ORCID,Rovelli Attilio,Biagi Ettore,Galimberti Stefania^ORCID,Calabria Andrea^ORCID,Benedicenti Fabrizio,Montini Eugenio,Ferrari Silvia^ORCID,Introna Martino,Balduzzi Adriana^ORCID,Valsecchi Maria Grazia,Dastoli Giuseppe,Rambaldi Alessandro^ORCID,Biondi Andrea

Funder

Ministero della Salute

Cancer Research UK

Associazione Italiana per la Ricerca sul Cancro

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/138473/files/pdf

Reference69 articles.

1. Clinical lessons learned from the first leg of the CAR T cell journey